Mayflower Financial Advisors, LLC Eli Lilly & CO Transaction History

Mayflower Financial Advisors, LLC

$629 Million
Q3 2024

A detailed history of Mayflower Financial Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Mayflower Financial Advisors, LLC holds 3,135 shares of LLY stock, worth $2.47 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

3,135

Previous 3,098 1.19%

Holding current value

$2.47 Million

Previous $2.8 Million 0.96%

% of portfolio

0.44%

Previous 0.22%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$772.14 - $960.02 $28,569 - $35,520	37 Added 1.19%	3,135 $2.78 Million
Q2 2024 Aug 02, 2024	BUY	$724.87 - $909.04 $47,841 - $59,996	66 Added 2.18%	3,098 $2.8 Million
Q1 2024 Apr 29, 2024	SELL	$592.2 - $792.28 $63,365 - $84,773	-107 Reduced 3.41%	3,032 $2.36 Million
Q4 2023 Jan 22, 2024	BUY	$525.19 - $619.13 $32,561 - $38,386	62 Added 2.01%	3,139 $1.83 Million
Q3 2023 Oct 12, 2023	SELL	$434.7 - $599.3 $3.26 Million - $4.5 Million	-7,506 Reduced 70.93%	3,077 $1.65 Million
Q2 2023 Jul 13, 2023	BUY	$350.74 - $468.98 $2,104 - $2,813	6 Added 0.06%	10,583 $4.96 Million
Q1 2023 Apr 12, 2023	SELL	$310.63 - $364.82 $220,547 - $259,022	-710 Reduced 6.29%	10,577 $3.63 Million
Q4 2022 Jan 25, 2023	BUY	$321.55 - $374.67 $3.63 Million - $4.23 Million	11,287 New	11,287 $0
Q3 2022 Oct 19, 2022	BUY	$296.48 - $337.87 $2.95 Million - $3.36 Million	9,941 Added 745.2%	11,275 $3.65 Million
Q3 2022 Oct 17, 2022	SELL	$296.48 - $337.87 $757,209 - $862,919	-2,554 Reduced 65.69%	1,334 $431,000
Q2 2022 Jul 15, 2022	SELL	$278.73 - $327.27 $6,689 - $7,854	-24 Reduced 0.61%	3,888 $1.26 Million
Q1 2022 Apr 21, 2022	BUY	$234.69 - $291.66 $25,111 - $31,207	107 Added 2.81%	3,912 $1.12 Million
Q4 2021 Jan 21, 2022	BUY	$224.85 - $279.04 $4,721 - $5,859	21 Added 0.55%	3,805 $1.05 Million
Q3 2021 Oct 26, 2021	BUY	$221.6 - $272.71 $7,756 - $9,544	35 Added 0.93%	3,784 $917,000
Q2 2021 Jul 29, 2021	SELL	$180.55 - $233.54 $23,471 - $30,360	-130 Reduced 3.35%	3,749 $861,000
Q1 2021 Apr 23, 2021	BUY	$164.32 - $212.72 $6,079 - $7,870	37 Added 0.96%	3,879 $725,000
Q4 2020 Apr 12, 2021	BUY	$130.46 - $172.63 $501,227 - $663,244	3,842 New	3,842 $649,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mayflower Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mayflower Financial Advisors, LLC with notifications on news.

Account

Mayflower Financial Advisors, LLC Eli Lilly & CO Transaction History